VEGFA and cancer: AD‐04 treatment caused a dramatic > 300‐fold decrease in secreted VEGF (sVEGF) in co‐culture systems containing primary human dermal fibroblasts (HDFs) co‐cultured with stimulated PBMCs in the presence or absence of human lung (H1299) or colorectal (HT‐29) cancer cells (Figure 1A).